These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34021132)

  • 21. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.
    Armstrong GA; Drapeau P
    Hum Mol Genet; 2013 Nov; 22(21):4282-92. PubMed ID: 23771027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma.
    Shiihashi G; Ito D; Arai I; Kobayashi Y; Hayashi K; Otsuka S; Nakajima K; Yuzaki M; Itohara S; Suzuki N
    EBioMedicine; 2017 Oct; 24():102-115. PubMed ID: 28928015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism.
    Murakami T; Yang SP; Xie L; Kawano T; Fu D; Mukai A; Bohm C; Chen F; Robertson J; Suzuki H; Tartaglia GG; Vendruscolo M; Kaminski Schierle GS; Chan FT; Moloney A; Crowther D; Kaminski CF; Zhen M; St George-Hyslop P
    Hum Mol Genet; 2012 Jan; 21(1):1-9. PubMed ID: 21949354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
    Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
    Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel interaction of FUS and syntaphilin may explain synaptic and mitochondrial abnormalities caused by ALS mutations.
    Salam S; Tacconelli S; Smith BN; Mitchell JC; Glennon E; Nikolaou N; Houart C; Vance C
    Sci Rep; 2021 Jun; 11(1):13613. PubMed ID: 34193962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.
    Vance C; Scotter EL; Nishimura AL; Troakes C; Mitchell JC; Kathe C; Urwin H; Manser C; Miller CC; Hortobágyi T; Dragunow M; Rogelj B; Shaw CE
    Hum Mol Genet; 2013 Jul; 22(13):2676-88. PubMed ID: 23474818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.
    Casci I; Krishnamurthy K; Kour S; Tripathy V; Ramesh N; Anderson EN; Marrone L; Grant RA; Oliver S; Gochenaur L; Patel K; Sterneckert J; Gleixner AM; Donnelly CJ; Ruepp MD; Sini AM; Zuccaro E; Pennuto M; Pasinelli P; Pandey UB
    Nat Commun; 2019 Dec; 10(1):5583. PubMed ID: 31811140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice.
    So E; Mitchell JC; Memmi C; Chennell G; Vizcay-Barrena G; Allison L; Shaw CE; Vance C
    Hum Mol Genet; 2018 Feb; 27(3):463-474. PubMed ID: 29194538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration.
    Szewczyk B; Günther R; Japtok J; Frech MJ; Naumann M; Lee HO; Hermann A
    Cell Rep; 2023 Feb; 42(2):112025. PubMed ID: 36696267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
    Sanjuan-Ruiz I; Govea-Perez N; McAlonis-Downes M; Dieterle S; Megat S; Dirrig-Grosch S; Picchiarelli G; Piol D; Zhu Q; Myers B; Lee CZ; Cleveland DW; Lagier-Tourenne C; Da Cruz S; Dupuis L
    Mol Neurodegener; 2021 Sep; 16(1):61. PubMed ID: 34488813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice.
    Shiihashi G; Ito D; Yagi T; Nihei Y; Ebine T; Suzuki N
    Brain; 2016 Sep; 139(Pt 9):2380-94. PubMed ID: 27368346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disrupted autophagy and neuronal dysfunction in C. elegans knockin models of FUS amyotrophic lateral sclerosis.
    Baskoylu SN; Chapkis N; Unsal B; Lins J; Schuch K; Simon J; Hart AC
    Cell Rep; 2022 Jan; 38(4):110195. PubMed ID: 35081350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
    López-Erauskin J; Tadokoro T; Baughn MW; Myers B; McAlonis-Downes M; Chillon-Marinas C; Asiaban JN; Artates J; Bui AT; Vetto AP; Lee SK; Le AV; Sun Y; Jambeau M; Boubaker J; Swing D; Qiu J; Hicks GG; Ouyang Z; Fu XD; Tessarollo L; Ling SC; Parone PA; Shaw CE; Marsala M; Lagier-Tourenne C; Cleveland DW; Da Cruz S
    Neuron; 2018 Nov; 100(4):816-830.e7. PubMed ID: 30344044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43.
    Lanson NA; Maltare A; King H; Smith R; Kim JH; Taylor JP; Lloyd TE; Pandey UB
    Hum Mol Genet; 2011 Jul; 20(13):2510-23. PubMed ID: 21487023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
    Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
    Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
    Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
    Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.